Somatotropin (176-191) (CAS 66004-57-7) – Wholesale & Research Grade
Somatotropin (176-191), also known as growth hormone-releasing peptide or GH fragment, is a peptide derived from the human growth hormone. It has garnered significant interest in the fields of endocrinology and sports medicine due to its potential applications in muscle growth, fat loss, and metabolic enhancement. Researchers are exploring its role in various therapeutic settings, including obesity treatment and age-related muscle wasting.
Research Applications
The primary research applications of Somatotropin (176-191) include its use as a performance-enhancing agent and its implications in anti-aging therapies. Studies have shown that this peptide can stimulate lipolysis, promoting fat loss while preserving lean muscle mass. Additionally, its ability to modulate insulin sensitivity has led to investigations into its potential for managing metabolic disorders.
Mechanism of Action
Somatotropin (176-191) operates by mimicking the effects of natural growth hormone, specifically targeting the release of fatty acids from adipocytes. This action facilitates increased energy expenditure and reduces fat accumulation. Furthermore, it influences the growth hormone receptor pathways, which may contribute to enhanced muscle growth and recovery.
Solubility and Storage
This peptide exhibits solubility in aqueous solutions, making it suitable for various formulations in both research and therapeutic applications. It is advisable to store Somatotropin (176-191) in a cool, dry place, ideally at temperatures below -20°C to maintain its stability and efficacy. When reconstituted, the solution should be used promptly and kept refrigerated to prevent degradation.
Future Research Directions
- Investigating the long-term effects of Somatotropin (176-191) on metabolic health and muscle preservation.
- Exploring its potential as a treatment for chronic conditions associated with aging, such as sarcopenia and metabolic syndrome.
- Conducting clinical trials to establish safety profiles and therapeutic dosages for various populations.
As research continues to unfold, Somatotropin (176-191) holds promise for a range of applications that could significantly impact health and wellness.
| CAS Number | 66004-57-7 |
|---|---|
| Formula | C78H123N23O22S2 |
| Mol. Weight | 1799.1 g/mol |
| IUPAC Name | [(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]... |
| Grade | HPLC ≥98% |
Synthesis & Storage
Somatotropin is supplied as a lyophilized powder to ensure stability during transit.
For long-term storage of CAS 66004-57-7, we recommend maintaining at -20°C.
Researchers must reconstitute this peptide with bacteriostatic water or sterile solvent only when ready for use.
Quality Control: All batches undergo rigorous HPLC purity testing (≥98%) prior to dispatch from our USA fulfillment center.